Association of IFNL2 (IL-28A) gene polymorphisms and human herpesvirus-7 detection in patients with chronic myeloid leukaemia
DOI:
https://doi.org/10.38029/babcockuniv.med.j..v8i2.1292Keywords:
IL-28, Polymorphism, HHV7, Chronic Myeloid Leukaemia, PCRAbstract
Objective: This study aimed to investigate the potential association between genetic polymorphisms in the IFNL2 (IL-28A) gene, detection of Human Herpesvirus-7 (HHV-7) DNA, and susceptibility to Chronic Myeloid Leukaemia (CML) in an Iraqi population.
Methods: A case-control study was conducted involving 100 CML patients and 100 apparently healthy controls (AHC). Genomic DNA was extracted from peripheral blood. IFNL2 gene polymorphisms were analysed by PCR amplification of a 604 bp fragment followed by Sanger sequencing. HHV-7 DNA was detected using conventional PCR targeting a 458 bp fragment. Genotype and allele frequencies were compared using Chi-square and Fisher's exact tests. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for age and sex.
Results: The distribution of IFNL2 genotypes differed significantly between CML patients and controls (p<0.05). The CC (wild-type) genotype was less frequent in patients (44%) than in controls (72%), while the CT (heterozygous) genotype was more frequent in patients (34%) than in controls (12%). The CT genotype was associated with significantly increased odds of CML (adjusted OR: 3.86, 95% CI: 1.21-12.33, p=0.022). HHV-7 DNA was detected in 19% (19/100) of CML patients but in none of the controls (0/100), a statistically significant difference (p<0.001).
Conclusion: The findings suggest a potential association between IFNL2 gene polymorphisms, HHV-7 infection, and CML susceptibility. The CT genotype and HHV-7 detection were significantly more prevalent in CML patients. These factors may represent host-viral interaction pathways relevant to CML pathogenesis, though further validation in larger cohorts is warranted.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mohammed SS, Almahbobi TF, Ibrahim MS, Al-Alwany SHM

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
